The Possibility of DNA Methylation for Precision Medicine in Colorectal Cancer.

Juntendo Med J · 2025 · PMC12257223 · PMID 40666491

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp = 0.10so close (0.05 < p ≤ 0.1)

A similar analysis in cases treated with first-line systemic chemotherapy with irinotecan also showed a trend for better disease control in the CHFR-RMV high group (83.3% vs. 46.2%, p = 0.10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.